Showing results (2261-2270 of 2,503) with videos related to

Sort By:
Pageof 251
Circulation|July 28, 2010
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary interventionMauricio G Cohen, Drew A Purdy, Joseph S Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic MelanomaWim H J Kruit, Stefan Suciu, Brigitte Dreno, et al.
Circulation|May 22, 2002
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluationChristopher K Dyke, Richard C Becker, Neal S Kleiman, et al.
Pain Medicine (Malden, Mass.)|September 24, 2016
Cigarette Smoking Status and Receipt of an Opioid Prescription Among Veterans of Recent WarsLori A Bastian, Mary A Driscoll, Alicia A Heapy, et al.
The New England Journal of Medicine|September 1, 2009
Ticagrelor versus clopidogrel in patients with acute coronary syndromesLars Wallentin, Richard C Becker, Andrzej Budaj, et al.
Circulation|February 21, 2014
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)Matthew W Sherwood, James D Douketis, Manesh R Patel, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 17, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AFSean T Chen, Anne S Hellkamp, Richard C Becker, et al.
Addiction Biology|March 25, 2026
Engaging Gut-to-Brain Signalling to Treat Alcohol Use DisorderPaula L Hoffman, Giordano de Guglielmo, Valentina Vengeliene, et al.
Heart (British Cardiac Society)|February 19, 2016
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxabanGünter Breithardt, Helmut Baumgartner, Scott D Berkowitz, et al.
Hypertension (Dallas, Tex. : 1979)|May 5, 2020
Subclinical Systolic and Diastolic Dysfunction Is Evident in Youth With Elevated Blood PressureAndrew H Tran, Joseph T Flynn, Richard C Becker, et al.
Pageof 251